Abstract
1740P Surufatinib combined with gemcitabine in soft tissue sarcoma (STS) patients failed with anthracyclines chemotherapy or monotherapy post-anlotinib progression: A multi-center, phase II trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have